Therapeutic Asset Ratings
6,308 results matching 1 filter
91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
carbidopa
Orthostatic Hypotension
Julien Bally
P1/2
CCC
(48)
Carboplatin
Colorectal Adenocarcinoma
Akeso
P1/2
CCC
(48)
Carboplatin
Gastroesophageal Junction Adenocarcinoma
Neonc Technologies, Inc.
P1/2
CCC
(48)
Carcik-Cd19
B-Cell Non-Hodgkin Lymphoma
Fondazione Matilde Tettamanti Menotti De Marchi Onlus
P1/2
CCC
(48)
Car-Nk Cell
Sjogren Syndrome
Bangdong Gong
P1/2
CCC
(48)
Cart84
Acute Myeloid Leukemia
Gyala Therapeutics
P1/2
CCC
(48)
Cart84
T-Cell Leukemia
Gyala Therapeutics
P1/2
CCC
(48)
CARVEDILOL
Traumatic Brain Injury
Mansoura University
P1/2
CCC
(48)
Cbp-1019
Breast Cancer
Coherent Biopharma (Hefei) Co., Ltd.
P1/2
CCC
(48)
Cbp-1019
Colorectal Cancer
Coherent Biopharma (Hefei) Co., Ltd.
P1/2
CCC
(48)
Cbp-1019
Lung Cancer
Coherent Biopharma (Hefei) Co., Ltd.
P1/2
CCC
(48)
Cbp-1019
Esophageal Cancer
Coherent Biopharma (Hefei) Co., Ltd.
P1/2
CCC
(48)
C-Car088
Plasma Cell Myeloma
Institute of Hematology & Blood Diseases Hospital, China
P1/2
CCC
(48)
cd123-car-nk cells
CD4+/CD56+ Hematodermic Neoplasm
Chongqing Precision Biotech Co., Ltd
P1/2
CCC
(48)
cd123-car-nk cells
Leukemia
Chongqing Precision Biotech Co., Ltd
P1/2
CCC
(48)
cd146/her2 car-t cells
Ewing Sarcoma
Essen Biotech
P1/2
CCC
(48)
cd146/her2 car-t cells
Kaposi'S Sarcoma
Essen Biotech
P1/2
CCC
(48)
cd146/her2 car-t cells
Bone Sarcoma
Essen Biotech
P1/2
CCC
(48)
cd146/her2 car-t cells
Large-Cell Immunoblastic Lymphoma
Essen Biotech
P1/2
CCC
(48)
cd146/her2 car-t cells
Soft Tissue Sarcoma
Essen Biotech
P1/2
CCC
(48)
cd146/her2 car-t cells
Synovial Sarcoma
Essen Biotech
P1/2
CCC
(48)
cd19-car_lenti t cell
Primary Mediastinal Large B-Cell Lymphoma
Bambino Gesù Hospital and Research Institute
P1/2
CCC
(48)
cd19/cd20 dual-car-t cells
B-Cell Neoplasm
Han weidong
P1/2
CCC
(48)
cd19 specific chimeric antigen receptor t cell
Follicular Lymphoma
Pell Bio-Med Technology Co., Ltd.
P1/2
CCC
(48)
cd3/cd19 negative allogeneic hematopoietic stem cells
Chronic Granulomatous Disease
Paul Szabolcs
P1/2
CCC
(48)
Showing 951 to 975 of 6,308 assets
Previous
Page 39 of 253
Next